Evidence map›Paper›PMID 28937851›Full record

ArticleHuman vaccines & immunotherapeutics2018

HPV vaccine acceptability in high-risk Greek men.

Lea Hoefer, Savas Tsikis, George Bethimoutis, Electra Nicolaidou, Vassilios Paparizos, Christina Antoniou, Antonios Kanelleas, Leonidas Chardalias, Georgios-Emmanouil Stavropoulos, John Schneider and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
  6. Factors Related to HPV Vaccination Intention among MSM in China: A Bayesian Network Model.International journal of environmental research and public health · 2022
    Article
  7. HPV vaccine for men: Where to? (Review).Experimental and therapeutic medicine · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Lea Hoefera Biological Sciences Division , University of Chicago Pritzker School of Medicine , Chicago , USA.
Savas Tsikisa Biological Sciences Division , University of Chicago Pritzker School of Medicine , Chicago , USA.
George Bethimoutisb 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.
Electra Nicolaidoub 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.
Vassilios Paparizosb 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.
Christina Antonioub 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.
Antonios Kanelleasb 1st Department of Dermatology and Venereology , National and Kapodistrian University of Athens School of Medicine, "Andreas Syggros" Hospital , Athens , Greece.
Leonidas Chardaliasc National and Kapodistrian University of Athens School of Medicine , Athens , Greece.
Georgios-Emmanouil Stavropoulosc National and Kapodistrian University of Athens School of Medicine , Athens , Greece.
John Schneiderd University of Chicago Medicine , Department of Medicine , Chicago , USA.
Angella Charnot-Katsikasf University of Chicago Medicine , Department of Pathology , Chicago , USA.
National and Kapodistrian University of Athens · GRAndreas Sygros Hospital · GRUniversity of Chicago · USChicago Department of Public Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HPV is associated with malignancy in men, yet there is a lack of data on HPV knowledge, vaccine acceptability, and factors affecting vaccine acceptability in Greek men. This study aims to identify determinants of knowledge and willingness to vaccinate against HPV among high-risk Greek men. Men (n = 298) between the ages of 18 and 55 were enrolled from the STI and HIV clinics at "Andreas Syggros" Hospital in Athens, Greece from July-October 2015. Participants completed a survey on demographics, economic factors, sexual history, HPV knowledge, and vaccine acceptability. The majority of participants were younger than 40 (76.6%) and unmarried (84.6%). Our sample was 31.2% MSM (men who have sex with men), and 20.1% were HIV-positive. Most participants (>90%) were aware that HPV is highly prevalent in both men and women; however, fewer identified that HPV causes cancers in both sexes (68%) and that vaccination protects men and women (67%). Amongst participants, 76.7% were willing to vaccinate themselves against HPV, 71.4% an adolescent son, and 69.3% an adolescent daughter. HIV-positive men were more likely to be willing to vaccinate themselves (OR 2.83, p = .015), a son (OR 3.3, p = .015) or a daughter (3.01, p = .020). Higher income levels were associated with increased willingness to vaccinate oneself (OR 1.32, p = .027), a son (1.33, p = .032) or daughter (1.34, p = .027). Although there is a HPV knowledge gap, HPV vaccine acceptability is high despite lack of vaccine promotion to Greek men. Future studies should include lower-risk men to adequately inform public health efforts.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultFemaleGreeceHumansMaleMiddle AgedNeoplasmsPapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CarePrevalenceSex FactorsSexual and Gender MinoritiesSurveys and QuestionnairesPapillomavirus VaccinesAttitudesHPVMenPatients-viewsVaccination

Identifiers

PMID28937851
PMCPMC5791582
OpenAlexW2760078856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.